Arginetix raises $2.3 million
Arginetix Inc., a Baltimore-based developer of small molecule inhibitors of arginase, has raised $2.3 million in first-round funding.
Glenmark Pharmaceuticals, a research-driven, global, integrated pharmaceutical, has said that it will raise INR12 billion.